Subscribe To
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of infinity pharmaceuticals, inc. – infi
NEW YORK, Aug. 26, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Infinity ...
August 26, 2023, 5:26 pm
Rosen, skilled investor counsel, encourages apellis pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – apls
NEW YORK, Aug. 26, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis
August 26, 2023, 2:44 pm
The mighty teva pharmaceutical: unveiling a bullish scenario you must consider
On August 2, Teva pharmaceutical published its financial report for the second quarter of 2023, which s...
August 26, 2023, 7:43 am
Prediction: these could be the best-performing cannabis stocks through 2030
Jazz pharmaceuticals and Innovative Industrial Properties have been standouts in the cannabis industry....
August 26, 2023, 7:25 am
Corcept therapeutics: far more constructive with korlym resolve (rating upgrade)
Corcept Therapeutics' equity stock shows promising investment prospects with the resolution of its Korlym overhang and strong financial performance. T...
August 26, 2023, 6:43 am
Ironwood: pipeline progresses as fda approves linzess
Ironwood pharmaceuticals specializes in the development and commercialization of drugs for gastrointest...
August 26, 2023, 2:18 am
Rosen, skilled investor counsel, encourages infinity pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – infi
NEW YORK, Aug. 25, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
August 25, 2023, 9:06 pm
Alnylam to appeal ruling on patents related to moderna's covid vaccines
Alnylam pharmaceuticals said on Friday it plans to appeal a ruling by the U.S. District Court for the D...
August 25, 2023, 6:05 pm
Softbank-backed neumora therapeutics files paperwork for u.s. ipo
Biopharmaceutical firm Neumora Therapeutics, which is backed by biotech Amgen and Japan's SoftBank , fi...
August 25, 2023, 5:51 pm
Werewolf: q4 2023 data readout and enhancement of validated targets
Preliminary safety and biomarker results from the phase 1/1b study, using WTX-124 for the treatment of patients with solid tumors, expected Q4 of 2023...
August 25, 2023, 4:48 pm
Inside tema etfs' new oncology etf (canc)
Oncology treatment has witnessed remarkable progress due to the relentless efforts of pharmaceutical co...
August 25, 2023, 3:02 pm
Aptargroup ceo: pharmaceutical consumer goods demand continues to be strong since covid
AptarGroup CEO Stephan Tanda joins 'The Exchange' to discuss business trends in pharmaceutical retail p...
August 25, 2023, 1:53 pm
Is takeda pharmaceutical co. (tak) stock undervalued right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
August 25, 2023, 11:16 am
Why is ys biopharma (ys) stock up 71% today?
YS Biopharma (NASDAQ: YS ) stock is rising higher on Friday after the biopharmaceutical company announ...
August 25, 2023, 8:00 am
Why is ys biopharma (ys) stock up 71% today?
YS Biopharma (NASDAQ: YS ) stock is rising higher on Friday after the biopharmaceutical company announ...
August 25, 2023, 7:59 am
High-intensity sweeteners market size worth usd 4.57 billion by 2030 at 7.15 cagr – report by market research future (mrfr)
High-Intensity Sweeteners Market Research Report Information by Product (sucralose, stevioside, acesulfame K, aspartame, cyclamate, glycyrrhizin, sacc...
August 25, 2023, 7:00 am
3 dividend stocks to buy on sale
One regional bank stands out among peers in important operational ratios. Investors may have overreacted to falling demand for this ...
August 25, 2023, 5:35 am
Better ai biotech stock: recursion pharmaceuticals vs. 23andme
AI for drug development is very fashionable in biotech, and for good reason. 23andMe's consumer business could one day provide a bedrock of stability....
August 25, 2023, 5:10 am
Fructose market to touch usd 11.54 billion by 2030, attaining a cagr of 3.46% between 2022 and 2030 – report by market research future (mrfr)
Fructose Market Research Report Information By Source (Sugarcane, Sugar Beet, Corn, and Others), By Product (High Fructose Corn Syrup, Fructose Syrup,...
August 24, 2023, 11:00 pm
Connect biopharma to participate in upcoming september investor conferences
SAN DIEGO and TAICANG, China, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “C...
August 24, 2023, 6:21 pm